Safety and efficacy of glucagon-like peptide-1 (GLP-1) receptor agonists in patients with weight regain or insufficient weight loss after metabolic bariatric surgery: A systematic review and meta-analysis.
代謝性減重手術後體重回升或減重不足患者使用胰高血糖素樣肽-1 (GLP-1) 受體激動劑的安全性與療效:系統性回顧與統合分析。
Obes Rev 2024-08-12
Efficacy of the Glucagon-Like Peptide-1 Receptor Agonists Liraglutide and Semaglutide for the Treatment of Weight Regain After Bariatric surgery: a Retrospective Observational Study.
胰高血糖素樣肽-1受體激動劑利拉魯肽和塞瑪魯肽治療胃潰瘍手術後體重回升的療效:一項回顧性觀察研究。
Obes Surg 2023-04-26
Efficacy and Safety of Glucagon-Like Peptide-1 Receptor Agonists on Body Weight and Cardiometabolic Parameters in Individuals With Obesity and Without Diabetes: A Systematic Review and Meta-Analysis.
肥胖且無糖尿病個體中胰高血糖素樣肽-1受體激動劑對體重和心臟代謝參數的功效和安全性:系統性回顧和荟萃分析。
Endocr Pract 2024-02-06
Efficacy of High-dose Liraglutide 3.0 mg in Patients with Poor Response to Bariatric Surgery: Real-world Experience and Updated Meta-analysis.
巨量利拉魯肽 3.0 毫克在對減重手術反應不佳的患者中的療效:實際世界經驗與最新的荟萃分析。
Obes Surg 2024-04-25
The impact of glucagon-like peptide-1 receptor agonists (GLP-1 RA) on weight loss following bariatric treatment: a systematic review and meta-analysis.
胰高血糖素樣肽-1受體激動劑(GLP-1 RA)對肥胖治療後體重減輕的影響:系統性回顧與荟萃分析。
J Clin Endocrinol Metab 2024-03-15
Glucagon-Like Peptide-1 Receptor Agonists in Post-bariatric Surgery Patients: A Systematic Review and Meta-analysis.
胰高血糖素樣肽-1受體激動劑在術後肥胖手術患者中的系統性回顧和荟萃分析。
Obes Surg 2024-05-06
A Review and Meta-Analysis of the Safety and Efficacy of Using Glucagon-like Peptide-1 Receptor Agonists.
使用胰高血糖素樣肽-1受體激動劑的安全性和有效性評論與荟萃分析。
Medicina (Kaunas) 2024-03-30
Liraglutide for the Treatment of Weight Regain After Bariatric Surgery: A Systematic Review and Meta-analysis.
Liraglutide用於肥胖手術後體重回升的治療:系統性回顧和荟萃分析。
Obes Surg 2024-07-10
Role of GLP1-RA in Optimizing Weight Loss Post-Bariatric Surgery: A Systematic Review and Meta-Analysis.
GLP1-RA 在優化減重後的減肥手術中的角色:系統性回顧與統合分析。
Obes Surg 2024-08-31
The Antiobesity Effect and Safety of GLP-1 Receptor Agonist in Overweight/Obese Adolescents Without Diabetes Mellitus: A Systematic Review and Meta-Analysis.
GLP-1 受體激動劑在無糖尿病的超重/肥胖青少年中的抗肥胖效果及安全性:系統性回顧與統合分析。
Cureus 2024-09-06